Dr. Till on the Potential to Utilize CAR T-Cell Therapy Earlier in MCL

SCCA’s Brian Till, MD, discussed the potential to utilize CAR T-cell therapy earlier in the treatment of patients with mantle cell lymphoma.

Watch the OncLive Interview